mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |